Oral Semaglutide under Human Protocols and Doses Regulates Food Intake, Body Weight, and Glycemia in Diet-Induced Obese Mice

Oral Semaglutide under Human Protocols and Doses Regulates Food Intake, Body Weight, and Glycemia in Diet-Induced Obese Mice

The first oral form of the glucagon-like peptide-1 receptor agonist, oral semaglutide, has recently been launched and potently controls glycemia and body weight in subjects with type 2 diabetes. This drug carries the absorption enhancer and requires specific protocols of administration. The mechanis...

Full description

Bibliographic Details
Main Authors: Yermek Rakhat, Lei Wang, Wanxin Han, Aktolkyn Rustemova, Nazymgul Kulzhanova, Yuichiro Yamada, Daisuke Yabe, Yutaka Seino, Toshihiko Yada
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Nutrients
Subjects:
oral semaglutide
GLP-1 receptor agonist
obesity
diabetes
food intake
body weight
Online Access:https://www.mdpi.com/2072-6643/15/17/3765

Internet

https://www.mdpi.com/2072-6643/15/17/3765

Similar Items